A U.S. appeals court has reinstated more than 500 lawsuits against drugmaker Merck & Co. because of its osteoporosis drug Fosamax, which plaintiffs allege increases risk of thigh bone fractures, ...

Shares of Merck & Co. Inc. MRK shed 1.31% to $115.63 Monday, on what proved to be an all-around great trading session for the ...

Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks ...

In this clip, from Forbes 30 Under 30 Summit, Ken Frazier explains the benefits of investing in your economy. Frazier is an ...

Ethereum, or 1 ETH, traded at $2,644.63 as of 8 a.m. ET. The highest intraday price the cryptocurrency reached in the past ...

More than 500 lawsuits, which a U.S. appeals court revived on Friday, allege Merck & Co. failed to warn patients that its osteoporosis drug Fosamax raised the risk of thigh bone fractures. Separately, ...

In a report released today, Terence Flynn from Morgan Stanley maintained a Hold rating on Merck & Company (MRK – Research Report), ...

Discover the FlexShares Quality Dividend Defensive Index Fund (QDEF) for potential capital gains with limited volatility and ...

After penning a letter to the world’s cardinals asking them to focus on financial reform, urging spending cuts and ...

Reuters.com is your online source for the latest news stories and current events, ensuring our readers up to date with any ...

A U.S. appeals court revived a lawsuit on Friday by healthcare and drug industry groups challenging the first-ever U.S. law ...

A U.S. appeals court on Friday revived more than 500 lawsuits alleging that Merck & Co failed to warn that its osteoporosis ...